Yujin Hoshida
University of Texas Southwestern Medical Center
Appearances
DateMay 8, 2023SOCIETY: AASLDModerators
University of Texas Southwestern Medical CenterUniversity of California Los Angeles
DateMay 21, 2024BACKGROUND: With the recent increase in metabolic liver diseases and viral hepatitis on anti-viral agents, risk stratification biomarkers are urgently needed to identify cirrhosis patients who should be prioritized for hepatocellular carcinoma (HCC) screening for early detection…Presenter
Speakers
University of MichiganMayo Foundation for Medical Education and ResearchBaylor College of MedicineBaylor University Medical CenterMichael E. DeBakey VAMCBaylor College of MedicineUT Southwestern Medical CenterUniversity of Texas Southwestern Medical Center
DateMay 19, 2024SOCIETY: AASLDModerators
University of Texas Southwestern Medical CenterUniversity of Pennsylvania Division of Gastroenterology
